UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 646

Sortiert nach

Huge Primary Cardiac Undifferentiated Pleomorphic Sarcoma

Internal Medicine, 2024/06/15, Vol.63(12), pp.1839-1840

2024

Link zum Volltext

Verfügbarkeit prüfen

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Japanese journal of clinical oncology, 2019-08, Vol.49 (8), p.762-765

2019

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Corticosteroid Administration and Survival Period in Terminal Cancer Patients

Journal of palliative care, 2024-07, Vol.39 (3), p.238-243

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Japanese journal of clinical oncology, 2020-12, Vol.50 (12), p.1447-1453

2020

Link zum Volltext

Verfügbarkeit prüfen

Demand for weekend outpatient chemotherapy among patients with cancer in Japan

Supportive care in cancer, 2021-03, Vol.29 (3), p.1287-1291

2021

Link zum Volltext

Verfügbarkeit prüfen

Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis

Internal Medicine, 2021/09/15, Vol.60(18), pp.2967-2971

2021

Link zum Volltext

Verfügbarkeit prüfen

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non-small Cell Lung Cancer

Molecular cancer therapeutics, 2021-09, Vol.20 (9), p.1653-1662

2021

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Randomized Clinical Trials Comparing Cisplatin to Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3852-3859

2004

Link zum Volltext

Verfügbarkeit prüfen

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

Acta oncologica, 2020-03, Vol.59 (3), p.249-256

2020

Link zum Volltext

Verfügbarkeit prüfen

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-06, Vol.132, p.54-58

2019

Link zum Volltext

Verfügbarkeit prüfen

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Internal Medicine, 2024/05/01, Vol.63(9), pp.1261-1267

2024

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer

Internal Medicine, 2021/04/15, Vol.60(8), pp.1183-1190

2021

Link zum Volltext

Verfügbarkeit prüfen

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Scientific reports, 2018-01, Vol.8 (1), p.1955-11, Article 1955

2018

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

Internal Medicine, 2022/02/01, Vol.61(3), pp.379-383

2022

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Biochemical and biophysical research communications, 2020-11, Vol.532 (3), p.341-346

2020

Link zum Volltext

Verfügbarkeit prüfen

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

Internal Medicine, 2021/09/01, Vol.60(17), pp.2831-2837

2021

Link zum Volltext

Verfügbarkeit prüfen

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

Internal Medicine, 2024, pp.2938-23

2024

Link zum Volltext

Verfügbarkeit prüfen

A Long-Term Survival Case of Coronary Artery Intimal Sarcoma

International Heart Journal, 2023/05/31, Vol.64(3), pp.483-486

2023

Link zum Volltext

Verfügbarkeit prüfen

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

PloS one, 2011-11, Vol.6 (11), p.e26646-e26646

2011

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Clinical cancer research, 2005-02, Vol.11 (3), p.1167-1173

2005

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002

Japanese journal of clinical oncology, 2013-11, Vol.43 (11), p.1115-1123

2013

Link zum Volltext

Verfügbarkeit prüfen

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R

Japanese journal of clinical oncology, 2021-05, Vol.51 (6), p.956-965

2021

Link zum Volltext

Verfügbarkeit prüfen

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

PloS one, 2009-11, Vol.4 (11), p.e7835

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 646

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(488)
Mit Volltextzugriff
(592)

Publikationsform

Sprache

Englisch
(554)
Japanisch
(231)

Erscheinungsjahr

n.n

Thema

Science & Technology
(369)
Life Sciences & Biomedicine
(314)
Humans
(269)
Male
(174)
Female
(160)
Oncology
(157)
Aged
(134)
Middle Aged
(130)
Biological And Medical Sciences
(106)
Lung Neoplasms - Drug Therapy
(105)
Medical Sciences
(96)
Adult
(81)
Treatment Outcome
(67)
Lung Cancer
(66)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(64)
Lung Neoplasms - Pathology
(62)
Respiratory System
(58)
Pneumology
(56)
Tumors Of The Respiratory System And Mediastinum
(55)
Aged, 80 And Over
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Huge Primary Cardiac Undifferentiated Pleomorphic Sarcoma

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Relationship Between Corticosteroid Administration and Survival Period in Terminal Cancer Patients

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Demand for weekend outpatient chemotherapy among patients with cancer in Japan

Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non-small Cell Lung Cancer

Meta-Analysis of Randomized Clinical Trials Comparing Cisplatin to Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

A Long-Term Survival Case of Coronary Artery Intimal Sarcoma

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

Aktive Filter

Suchergebnisse filtern